| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=0.1uM, (2S)-4-cyclohexyl-2-[[1-[(4-nitrophenyl)methyl]-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]amino]butanoic acid, Angiotensin AT2 Antagonists targeting AGTR2 (Novartis, 22878749) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/22878749 |
| Similar Terms | |
| Downloads & Tools |
2 genes differentially expressed following the CA-17-QL18_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| MYL6 | myosin, light chain 6, alkali, smooth muscle and non-muscle | 0.213029 |
| Symbol | Name | Standardized Value |
|---|---|---|
| LEMD2 | LEM domain containing 2 | -0.248777 |